| Document Date: 2013-02-24 13:49:01
Open Document File Size: 202,39 KBShare Result on Facebook
Company Gilead Sciences / / Event Product Issues / FDA Phase / / IndustryTerm Hepatitis B therapy / food / disoproxil fumarate-containing products / Healthcare providers / hepatitis B therapies / / MedicalCondition HBeAg- chronic hepatitis B / Fanconi syndrome / HIV / headache / HBV / myopathy / nausea / cirrhosis / compensated liver disease / hepatitis B / HIV RNA / Obesity / diarrhea / OF HEPATITIS / hepatitis / pruritus / liver disease / renal dysfunction / Steatosis Lactic acidosis / hepatic decompensation / compensated disease / Nutrition Disorders / SEVERE ACUTE EXACERBATIONS OF HEPATITIS / abdominal pain / untreated HIV infection / hypertension / umbilical hernia / Urinary Disorders / previously demonstrated hypersensitivity / hypophosphatemia / Carcinogenesis / Chronic / diabetes / chronic administration / lamivudine-resistant hepatitis B / vomiting / pain / renal insufficiency / Lactic acidosis / virus infection / Virus (HIV) infection / severe hepatitis / osteomalacia / histologically active disease / Connective Tissue Disorders / hypophosphatemia Gastrointestinal Disorders / renal failure / advanced liver disease / rash / chronic hepatitis B / posttransplantation lamivudine-resistant liver disease / / MedicalTreatment immunizations / Hemodialysis / dialysis / / Organization Chronic administration / DOSAGE AND ADMINISTRATION / FDA / / / Position Major / / Product efavirenz / cyclosporine / TRUVADA / HEPSERA / One tablet / tenofovir disoproxil fumarate / lamivudine / VIREAD / ATRIPLA / patients / Hemodialysis Patients / Renal Function / / PublishedMedium Microbiology / / Technology Transplantation / Pharmacokinetics / dialysis / / URL www.fda.gov/medwatch / /
SocialTag |
• HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA.